Compare NUS & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUS | AIRS |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.0M | 166.3M |
| IPO Year | 1996 | 2021 |
| Metric | NUS | AIRS |
|---|---|---|
| Price | $10.02 | $2.17 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.75 |
| AVG Volume (30 Days) | 446.7K | ★ 620.1K |
| Earning Date | 02-12-2026 | 11-07-2025 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $1,560,391,000.00 | $157,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.12 | $2.55 |
| P/E Ratio | $4.66 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.32 | $1.53 |
| 52 Week High | $14.62 | $12.00 |
| Indicator | NUS | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 31.83 |
| Support Level | $9.59 | $1.83 |
| Resistance Level | $10.35 | $2.24 |
| Average True Range (ATR) | 0.31 | 0.18 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 44.54 | 42.99 |
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.